Literature DB >> 15702610

Optimal population designs for PK models with serial sampling.

Robert Gagnon1, Sergei Leonov.   

Abstract

In various pharmaceutical applications, repeated measurements are taken from each subject, and model parameters are estimated from the collected data. Examples include dose response modeling and PK/PD studies with serial blood sampling, among others. The quality of the information in an experiment is reflected in the precision of estimates of model parameters, which is traditionally measured by their variance-covariance matrix. In this article, we concentrate on the example of a clinical PK study where multiple blood samples are taken for each enrolled patient, which leads to nonlinear mixed effects regression models with multiple responses. The sampling scheme for each patient is considered a multidimensional point in the space of admissible sampling sequences. We demonstrate how to optimize the precision of parameter estimates by finding the best number and allocation of sampling times. It is shown that a reduced number of samples may be taken without significant loss of precision of parameter estimates. Moreover, our approach allows for taking experimental costs into account, which leads to a more meaningful comparison of sampling schemes and to potential cost savings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702610     DOI: 10.1081/bip-200040853

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  9 in total

1.  Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.

Authors:  Joakim Nyberg; Caroline Bazzoli; Kay Ogungbenro; Alexander Aliev; Sergei Leonov; Stephen Duffull; Andrew C Hooker; France Mentré
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models.

Authors:  Federico Galvanin; Carlo C Ballan; Massimiliano Barolo; Fabrizio Bezzo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-06-04       Impact factor: 2.745

3.  Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-10       Impact factor: 2.745

4.  Efficient parameter estimation in multiresponse models measuring radioactivity retention.

Authors:  J M Rodríguez-Díaz; G Sánchez-León
Journal:  Radiat Environ Biophys       Date:  2019-02-25       Impact factor: 1.925

5.  Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.

Authors:  Vidya Perera; Robert R Bies; Gary Mo; Michael J Dolton; Vaughan J Carr; Andrew J McLachlan; Richard O Day; Thomas M Polasek; Alan Forrest
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

6.  Optimisation of sampling windows design for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-09       Impact factor: 2.745

7.  Population pharmacokinetics and optimal design of paediatric studies for famciclovir.

Authors:  Kayode Ogungbenro; Ivan Matthews; Michael Looby; Guenther Kaiser; Gordon Graham; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

8.  Optimal design of perturbations for individual two-compartment pharmacokinetic analysis.

Authors:  Matthew S Shotwell; Minchun Zhou; William H Fissell
Journal:  J Biopharm Stat       Date:  2015-08-06       Impact factor: 1.051

9.  Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.

Authors:  Kayode Ogungbenro; Ivelina Gueorguieva; Oneeb Majid; Gordon Graham; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-07       Impact factor: 2.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.